Market Cap 343.04M
Revenue (ttm) 1.04B
Net Income (ttm) -190.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 9.50
Profit Margin -18.26%
Debt to Equity Ratio 1.20
Volume 722,000
Avg Vol 1,294,284
Day's Range N/A - N/A
Shares Out 54.28M
Stochastic %K 20%
Beta 2.09
Analysts Sell
Price Target $13.50

Latest News on EBS

Emergent BioSolutions Announces Stock Repurchase Program

Mar 31, 2025, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Announces Stock Repurchase Program


Emergent BioSolutions: Stock Is A Likely Winner In 2025

Jan 14, 2025, 7:53 AM EST - 5 months ago

Emergent BioSolutions: Stock Is A Likely Winner In 2025


Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine

Aug 30, 2024, 7:15 AM EDT - 9 months ago

Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine


Health stocks jump as WHO declares mpox global health emergency

Aug 15, 2024, 11:26 AM EDT - 10 months ago

Health stocks jump as WHO declares mpox global health emergency


Emergent BioSolutions Inc. (EBS) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 10:48 PM EDT - 10 months ago

Emergent BioSolutions Inc. (EBS) Q2 2024 Earnings Call Transcript